News

Intravenous Immunoglobulin Quickly Lowers Disease Activity in AAV Patients, Review Study Finds

Intravenous immunoglobulin (IVIG) therapy leads to a fast and significant reduction in disease activity, as well as in the levels of inflammatory biomarkers, in people with ANCA-associated vasculitis (AAV), a review of several studies found. The study, “The therapeutic efficacy of intravenous immunoglobulin in anti-neutrophilic cytoplasmic antibody-associated…

ANCA Autoantibodies Produced in Healthy People, Study Shows

Healthy individuals also produce a type of self-reactive antibodies — termed IgM ANCA — present in people with ANCA-associated vasculitis (AAV), a study has found. While low, the levels in healthy people are comparable with those in AAV patients whose disease is less active. The antibodies’ role is still…

Development of Oral Candidiasis Predicts Severe Infections in AAV Patients Receiving Immunosuppressants, Study Shows

ANCA-associated vasculitis patients who develop oral candidiasis during treatment with immunosuppressants have a significantly greater risk of severe infections compared to patients who never develop oral candidiasis, a study shows. Together with use of methylprednisolone pulse therapy and higher serum albumin levels, oral thrush appears to be a significant…